Adjuvant nivolumab plus ipilimumab for kidney cancer
Adjuvant therapy is medication that is given after surgery to [...]
Health-related quality of life with lenvatinib in combination with everolimus
Maintaining good health-related quality of life is important for all [...]
Nivolumab compared to cabozantinib as a second- or third-line treatment
This study looked at real world data from people with [...]
Cabozantinib plus nivolumab and ipilimumab delays progression in kidney cancer
Preliminary results from the COSMIC-313 clinical trial have ben released. [...]
Statins improve the effectiveness of nivolumab for advanced kidney cancer
Statins are a group of medicines that can help lower [...]
AUA 2022: Should everyone have adjuvant therapy after surgery for high-risk kidney cancer?
The 2022 American Urological Association (AUA) Annual Meeting included a [...]
ASCO 2022: Sequencing of kidney cancer medicines
During the American Society of Clinical Oncology (ASCO) Annual Meeting [...]
Sequencing of treatments for advanced/metastatic kidney cancer
During the American Society of Clinical Oncology Annual Meeting earlier [...]
Three years follow-up data from the belzutifan study for pre-treated metastatic kidney cancer
Studies looking at the genes of people with kidney cancer [...]
Does the size of response to cabozantinib plus nivolumab affect clinical outcomes?
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
